Cargando…
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
The rapid emergence of SARS-CoV-2 variants is fueling the recent waves of the COVID-19 pandemic. Here, we assessed ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 Spikes. Both these variants carry some mutations shared by other emerging variants. Some of the pivotal mutations such as N501Y a...
Autores principales: | Chatterjee, Debashree, Tauzin, Alexandra, Laumaea, Annemarie, Gong, Shang Yu, Bo, Yuxia, Guilbault, Aurélie, Goyette, Guillaume, Bourassa, Catherine, Gendron-Lepage, Gabrielle, Medjahed, Halima, Richard, Jonathan, Moreira, Sandrine, Côté, Marceline, Finzi, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780535/ https://www.ncbi.nlm.nih.gov/pubmed/35062348 http://dx.doi.org/10.3390/v14010144 |
Ejemplares similares
-
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
por: Gong, Shang Yu, et al.
Publicado: (2021) -
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Chatterjee, Debashree, et al.
Publicado: (2022) -
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
por: Halfmann, Peter J., et al.
Publicado: (2022) -
A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2023) -
Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
por: Tauzin, Alexandra, et al.
Publicado: (2022)